132 related articles for article (PubMed ID: 230303)
21. The activity in vitro against herpes virus of 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine), a new antiviral agent.
Collins P; Bauer DJ
J Antimicrob Chemother; 1979 Jul; 5(4):431-6. PubMed ID: 489491
[No Abstract] [Full Text] [Related]
22. Acyclovir inhibition of viral DNA chain elongation in herpes simplex virus-infected cells.
McGuirt PV; Furman PA
Am J Med; 1982 Jul; 73(1A):67-71. PubMed ID: 6285735
[TBL] [Abstract][Full Text] [Related]
23. Acyclovir-resistant herpes simplex virus.
N Engl J Med; 1982 Sep; 307(11):681-2. PubMed ID: 6287259
[No Abstract] [Full Text] [Related]
24. Inhibition of herpes simplex virus type 1 DNA polymerase by [1R(1 alpha,2 beta,3 alpha)]-9-[2,3-bis(hydroxymethyl)cyclobutyl] guanine.
Terry BJ; Cianci CW; Hagen ME
Mol Pharmacol; 1991 Oct; 40(4):591-6. PubMed ID: 1656194
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of herpes simplex virus transformed and nontransformed cells by acycloguanosine: mechanisms of uptake and toxicity.
Davidson RL; Kaufman ER; Crumpacker CS; Schnipper LE
Virology; 1981 Aug; 113(1):9-19. PubMed ID: 6267792
[No Abstract] [Full Text] [Related]
26. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
Schnitzler P; Schön K; Reichling J
Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
[TBL] [Abstract][Full Text] [Related]
27. The effect of triterpenoid compounds on uninfected and herpes simplex virus-infected cells in culture. I. Effect on cell growth, virus particles and virus replication.
Dargan DJ; Subak-Sharpe JH
J Gen Virol; 1985 Aug; 66 ( Pt 8)():1771-84. PubMed ID: 2991440
[TBL] [Abstract][Full Text] [Related]
28. Anti-herpes simplex virus and cytostatic activity of some new 5-substituted 1-(4-hydroxybutyl)-and 1-(2-hydroxyethoxymethyl) uracil nucleoside analogues.
Reefschläger J; Herrmann G; Jennrich H; Frost N
Acta Virol; 1985 May; 29(3):185-93. PubMed ID: 2864819
[TBL] [Abstract][Full Text] [Related]
29. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
[TBL] [Abstract][Full Text] [Related]
30. Inhibition by interferon of herpes simplex virus thymidine kinase and DNA polymerase in infected and biochemically transformed cells.
Panet A; Falk H
J Gen Virol; 1983 Sep; 64 (Pt 9)():1999-2006. PubMed ID: 6193244
[TBL] [Abstract][Full Text] [Related]
31. Structure and conformation of the potent antiherpes agent 9-(2-hydroxyethoxymethyl) guanine (acycloguanosine).
Birnbaum GI; Cygler M; Kusmierek JT; Shugar D
Biochem Biophys Res Commun; 1981 Dec; 103(3):968-74. PubMed ID: 6277325
[No Abstract] [Full Text] [Related]
32. Mechanism of action and selectivity of acyclovir.
Elion GB
Am J Med; 1982 Jul; 73(1A):7-13. PubMed ID: 6285736
[TBL] [Abstract][Full Text] [Related]
33. Replication of herpesviruses in human cells transformed by cytomegalovirus.
Figueroa ME; Geder L; Rapp F
J Gen Virol; 1978 Aug; 40(2):391-8. PubMed ID: 211187
[TBL] [Abstract][Full Text] [Related]
34. Selective inhibition of the proliferation of herpes simplex virus type 1 thymidine kinase gene-transformed murine mammary FM3A carcinoma cells by (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
Balzarini J; De Clercq E; Ayusawa D; Shimizu K; Seno T
Nucleic Acids Symp Ser; 1985; (16):283-6. PubMed ID: 3003708
[TBL] [Abstract][Full Text] [Related]
35. Effect of acyclovir on herpes simplex virus replication in a persistently infected human lymphoblastoid cell line (P3HR-1).
Shaw JE; Colby BM; Leong J; Bolling TJ
Am J Med; 1982 Jul; 73(1A):72-6. PubMed ID: 6285737
[No Abstract] [Full Text] [Related]
36. Antiherpesviral and anticellular effects of 1-beta-D-arabinofuranosyl-E-5-(2-halogenovinyl) uracils.
Machida H; Sakata S; Kuninaka A; Yoshino H
Antimicrob Agents Chemother; 1981 Jul; 20(1):47-52. PubMed ID: 6269482
[TBL] [Abstract][Full Text] [Related]
37. Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro.
Nishiyama Y; Yamamoto N; Yamada Y; Daikoku T; Ichikawa Y; Takahashi K
J Antibiot (Tokyo); 1989 Dec; 42(12):1854-9. PubMed ID: 2559911
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiviral activity of carbocyclic oxetanocin analogues (C-OXT-A, C-OXT-G) and related compounds. II.
Maruyama T; Hanai Y; Sato Y; Snoeck R; Andrei G; Hosoya M; Balzarini J; De Clercq E
Chem Pharm Bull (Tokyo); 1993 Mar; 41(3):516-21. PubMed ID: 8386594
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of 2'-nor-cyclicGMP in treatment of experimental herpes virus infections.
Field AK; Davies ME; DeWitt CM; Perry HC; Schofield TL; Karkas JD; Germershausen J; Wagner AF; Cantone CL; MacCoss M
Antiviral Res; 1986 Oct; 6(6):329-41. PubMed ID: 3022643
[TBL] [Abstract][Full Text] [Related]
40. Characterization of antiviral activity of a sesquiterpene, triptofordin C-2.
Hayashi K; Hayashi T; Ujita K; Takaishi Y
J Antimicrob Chemother; 1996 Apr; 37(4):759-68. PubMed ID: 8722541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
